Chordoma: the slow rare tumor of the spine and skull base, and the centers that know it well
Last updated September 3, 2026.
A chordoma is a rare cancer that grows from remnants of the notochord, a structure that guides the developing spine before birth, and it appears along the spine from the skull base to the tailbone. It is slow-growing, which is both the trap and the opportunity: it is often present for years, dismissed as back pain or tailbone pain, before a scan finds it, and it is treated most successfully the first time, which makes where you are treated an unusually important decision. The treatment is surgery that removes the tumor in one piece with a margin around it, usually followed by high-dose, precisely targeted radiation, with proton therapy the frequent choice because it can deliver a high dose beside the spinal cord and brain. Chordomas do not respond to ordinary chemotherapy, though targeted drugs are used for the minority that spread. The honest framing: this is a serious, chronic cancer that can come back over years, and people live with it, often for a long time, with surveillance and, when needed, further treatment. The practical message is equally strong: outcomes track with being at a center that sees chordoma regularly, and patient communities and specialist registries can point you to them.
What does it look like?
It depends on the level. Skull-base chordomas press on nerves: double vision, headaches, facial numbness, swallowing or voice changes. Spinal ones cause pain at the level, sometimes with weakness, numbness, or bowel and bladder change. Tailbone, or sacral, chordomas cause deep sitting pain, sometimes a lump, and bowel, bladder, or sexual changes, and this is the presentation most often dismissed for years as ordinary back trouble.
Why does it happen?
Before birth, the notochord guides the forming spine and then dissolves; tiny remnants of it persist along the spine in everyone, and very rarely one turns cancerous decades later. It is not caused by injury, posture, or anything done or eaten, and it does not run in families except in a handful of documented families worldwide. It is, in the truest sense, bad cellular luck, in a place nobody can reach to prevent.
How is it treated?
- Surgery, done completely the first time, is the cornerstone. Removing the tumor in one piece with a margin of healthy tissue gives the best long-term control, and the first operation has the best chance, which is why the surgeon's chordoma experience matters so much.
- High-dose precision radiation usually follows. Proton therapy is often chosen because it can deliver a high dose millimeters from the spinal cord or brain, and the courses run for several weeks.
- Ordinary chemotherapy does not work on chordoma, and that is normal, not a dead end. For the minority that spread, targeted drugs and clinical trials exist, and a specialist center knows which apply to your tumor's testing.
- Surveillance is lifelong, and that is a plan, not a shadow. Scheduled MRI scans catch any recurrence early, when further surgery or radiation works best, and many people live full lives between scans.
When does it need prompt review?
Deep tailbone or spinal pain that persists for weeks despite ordinary measures, a lump at the tailbone, new double vision, or any new leg weakness, numbness, or bladder and bowel change deserves prompt review and, where indicated, an MRI. New loss of bladder or bowel control is a same-day emergency. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Eighteen months of being told it was coccydynia. Why was this missed?
Because the tumor is rare enough to be invisible to pattern-matching, and your story is the modal one, not an outlier. Most doctors will never see a chordoma in a career, and persistent tailbone pain is common and usually exactly what they called it. The label fails only when the pain outstays it, and getting the MRI at that point, the step your persistence forced, is how these tumors are usually found. The system failed you in the aggregate rather than any one person being careless, which does not make the eighteen months fine; it makes them explicable. The good news is practical: this tumor is slow, and the delay cost less than it would in a fast cancer.
They keep saying slow-growing like it is good news. Is it?
Yes, in two concrete ways. First, the past: slow growth means the eighteen undiagnosed months and even the years before them did far less harm than the same delay in a fast cancer, which is why a large tumor can still be highly treatable now. Second, the future: slow growth means the weeks spent getting to the right center are affordable, that recurrences, if they come, announce on surveillance scans years apart rather than ambushing, and that many people live with this as a long-term watched condition rather than a sprint. Slow is not a consolation prize here. It is the feature your whole plan is built on.
Why does the center matter so much? Surgery is surgery, surely.
In common operations, yes; in this one, no. Chordoma surgery aims to remove the tumor in one piece with a margin of healthy tissue around it, around some of the most delicate anatomy in the body, and the first operation has the best chance of being the complete one. Recurrence rates track with how completely that first operation is done, and completeness tracks with how many of these the surgeon and the team have done. This is one of the few cancers where the patient communities maintain what amounts to a map of the experienced centers, because in rare disease the patients hold the institutional knowledge. Ask for the referral by name, and let the community help you aim it.
What is proton radiation, and why that kind?
It is radiation with a physical property that suits your anatomy exactly. Ordinary X-ray radiation keeps depositing dose as it passes through the body; protons stop where you tell them to, delivering their maximum at the tumor and almost nothing beyond it. Beside the spinal cord, the sacral nerves, or the brain, that property lets the team give the high dose this tumor needs while sparing the structures millimeters away. The course is daily treatment over several weeks, the side effects are mostly fatigue and local skin and tissue irritation, and the logistics, including staying near the proton center, are a known routine the team will walk you through.
Why is there no chemotherapy for this?
Because chordoma cells divide slowly and shrug off the drugs ordinary chemotherapy uses, and everyone in the field knows it, so its absence from your plan is a fact about the tumor, not a gap in your care. The treatments that work are the physical ones, surgery and high-dose radiation, which is why they carry the plan. For the minority of chordomas that spread, the tumor's genetic testing opens a different cupboard: targeted drugs matched to specific mutations, and clinical trials the specialist centers know. Not being offered chemotherapy for chordoma is a sign your team knows the disease.
What does my life look like after all of this?
For many people: long, watched, and mostly ordinary. The first year holds the big operation and the radiation course, with recovery measured in months and some functions, bowel, bladder, sexual, walking, depending on the level and the operation, needing rehabilitation and honest adjustment. After that, the shape is surveillance: MRI scans on a schedule for life, because this tumor can return over years and catching a return early is when further treatment works best. Many people with chordoma work, travel, raise families, and describe a negotiation with the scans rather than a life ruled by the tumor. The terror belongs to the word cancer; the trajectory, at an experienced center, is frequently far better than the terror.